Emerging Systemic Therapy Options beyond CDK4/6 Inhibitors for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

The authors describe the findings from clinical trials using small molecule inhibitors, antibody–drug conjugates and immunotherapy, providing insights into how these novel strategies may circumvent treatment resistance.
[npj Breast Cancer]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News